UCLPartners

Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease

Retrieved on: 
Wednesday, February 8, 2023

People at risk of, or with, CVD are typically identified during an NHS Health Check.

Key Points: 
  • People at risk of, or with, CVD are typically identified during an NHS Health Check.
  • Dr Alex Warner, Clinical Director at Camden Health Partners, said, "As Camden GPs we are excited about the potential for this programme.
  • Kate Cheema, Director of Evaluation and Insights at UCLPartners, added: "UCLPartners is delighted to be working with HUMA as an evaluation partner.
  • It is the single biggest condition4 where lives can be saved by the UK's NHS over the next decade.

Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program

Retrieved on: 
Tuesday, January 18, 2022

Mahana Therapeutics , a leading developer of prescription digital therapeutics designed to empower people living with chronic health conditions, today announced that Mahana has been selected for the DigitalHealth.Londons Accelerator programme .

Key Points: 
  • Mahana Therapeutics , a leading developer of prescription digital therapeutics designed to empower people living with chronic health conditions, today announced that Mahana has been selected for the DigitalHealth.Londons Accelerator programme .
  • The program will help Mahana Therapeutics better engage with the NHS to accelerate adoption of Mahana IBS in clinical practice.
  • We are excited to join this prestigious program to accelerate adoption of and experience with Mahana IBS within the NHS.
  • Mahana Therapeutics is a leading developer of effective prescription digital therapeutics that are designed to empower patients with chronic conditions to live fuller lives.